Alzheimer's - Dementia, Author Interviews, Biomarkers, JAMA, MRI / 22.05.2023
Alzheimer’s Disease: Study Finds tau-PET Imaging Increases Diagnostic Accuracy
MedicalResearch.com Interview with:
Ruben Smith MD, PhD
Associate professor at Clinical Memory Research
Division of Neurology
Lund University
MedicalResearch.com: What is the background for this study?
Response: Since a few years it has become possible to visualize tau pathology in Alzheimer’s Disease (AD) using positron emission tomography (PET). The tau-PET radiotracer Flortaucipir (Tauvid) was recently approved by the US Food and Drug Administration as an AD diagnostic tool. Since PET imaging is costly and exposes the patient to radioactivity we wanted to study the added clinical value of tau-PET in the diagnostic work-up of patients with cognitive symptoms, before widespread implementation in clinical practice.
(more…)